Medline Inc Ordinary Shares - Class A MDLN
News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
MDLN Stock Alert: Medline Product Quality Issues and Subsequent 13% Stock Drop Trigger Securities Fraud Investigation for Investors
Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
Medline to report third quarter 2026 results on November 4, 2026
MDLN Stock Notice: Medline Stock Plummeted 13% after Product Quality Issues Disclosed - Securities Fraud Investigation Underway
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
Medline Legal Alert: Medline (MDLN) Investors who Lost Money are Notified of the Ongoing Securities Fraud Investigation
MDLN Stock Drop Alert: Medline Inc.’s Stock Drops 13% over Product Quality Issues Triggering Securities Fraud Investigation by BFA Law
Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm
MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm
NASDAQ: MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm
NASDAQ: MDLN Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm
Medline Reports Second Quarter and First Six Months 2026 Results
Medline's IPO underscores broad investor appetite for a sleepy corner of the healthcare business


